Product Wiki · Recalls · UK Food Standards Agency

Recall FSA-PRIN-29-2025-update-3 — name: Orgenism Eggshell Membrane Capsules

UK Food Standards Agency · GB · 2025-07-31 · Product Recall Information Notice

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
UK Food Standards Agency
Recall identifier
FSA-PRIN-29-2025-update-3
Date of alert
2025-07-31
Country / jurisdiction
GB
Risk level
Product Recall Information Notice
Risk type
PRIN
Brand
Orgenism
Product category
Food
Reported risk: The presence of Salmonella in the products listed above.  The Salmonella found produces extended-spectrum beta-lactamase (ESBL), and is resistant to several antibiotics, (fluoroquinolones, tetracycline and Fosfomycin), making it more difficult to treat. Inaccurate disposal of the product could cause wider public health, animal health or environmental risks therefore it is important to ensure you follow the advice on how to safely dispose of the product provided below. Symptoms caused by Salmonella usually include fever, diarrhoea and abdominal cramps. Public Health Authorities advise if you have consumed this product and have any concerns, you should seek advice from healthcare professionals, using the most appropriate route depending on where you live, (i.e., visit your GP, call NHS111).  Even if you feel well, return of the product is essential so that it can be disposed of in a way that does not contaminate the environment and put others at risk. Do not dispose of this product in household waste or flush the capsules down toilets.
Primary source: https://www.food.gov.uk/news-alerts/alert/fsa-prin-29-2025-update-3

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.